(VIANEWS) - Maiden Holdings, Ltd. (MHLD), Boston Scientific (BSX), Addus HomeCare Corporation (ADUS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Maiden Holdings, Ltd. (MHLD)
179.6% sales growth and 5.16% return on equity
Maiden Holdings, Ltd., through its subsidiaries, provides property and casualty reinsurance solutions to regional and specialty insurers in Europe, the United States, and internationally.
Maiden Holdings, Ltd.'s sales growth this year is anticipated to be 231.6% and a negative 0% for next year.
Year-on-year quarterly revenue growth declined by 46.5%, now sitting on 113.35M for the twelve trailing months.
Volume
Today's last reported volume for Maiden Holdings, Ltd. is 120749 which is 30.82% above its average volume of 92301.
Maiden Holdings, Ltd.'s sales growth for the next quarter is 179.6%. The company's growth estimates for the present quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.16%.
Volatility
Maiden Holdings, Ltd.'s last day, last week, and last month's current intraday variation average was 3.62%, 2.26%, and 1.64%, respectively.
Maiden Holdings, Ltd.'s highest amplitude of average volatility was 11.61% (day), 6.43% (last week), and 3.87% (last month), respectively.
Maiden Holdings, Ltd.'s Stock Yearly Top and Bottom Value
Maiden Holdings, Ltd.'s stock is valued at $2.76 at 15:22 EST, way under its 52-week high of $4.00 and way above its 52-week low of $2.17.
Maiden Holdings, Ltd.'s Moving Average
Maiden Holdings, Ltd.'s worth is under its 50-day moving average of $3.02 and way under its 200-day moving average of $3.26.2. Boston Scientific (BSX)
17.5% sales growth and 3.69% return on equity
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Boston Scientific's sales growth this year is expected to be 21.2% and 7.9% for next year.
Year-on-year quarterly revenue growth grew by 53.6%, now sitting on 11.2B for the twelve trailing months.
Volume
Today's last reported volume for Boston Scientific is 6616110 which is 28.09% below its average volume of 9201700.
Boston Scientific's sales growth is a negative 0% for the present quarter and 17.5% for the next. The company's growth estimates for the ongoing quarter and the next is 8.1% and 91.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.69%.
Volatility
Boston Scientific's last day, last week, and last month's current intraday variation average was 1.48%, 1.67%, and 1.31%, respectively.
Boston Scientific's highest amplitude of average volatility was 2.56% (day), 2.35% (last week), and 2.78% (last month), respectively.
Boston Scientific's Stock Yearly Top and Bottom Value
Boston Scientific's stock is valued at $43.11 at 15:22 EST, below its 52-week high of $46.29 and way higher than its 52-week low of $32.99.
Boston Scientific's Moving Average
Boston Scientific's value is under its 50-day moving average of $43.43 and under its 200-day moving average of $43.52.3. Addus HomeCare Corporation (ADUS)
12.6% sales growth and 7.6% return on equity
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.
Addus HomeCare Corporation's sales growth this year is expected to be 13.3% and 8.6% for next year.
Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 835.85M for the twelve trailing months.
Volume
Today's last reported volume for Addus HomeCare Corporation is 40663 which is 53.9% below its average volume of 88211.
Addus HomeCare Corporation's sales growth for the next quarter is 12.6%. The company's growth estimates for the present quarter and the next is 13.4% and 27%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.6%.
Volatility
Addus HomeCare Corporation's last day, last week, and last month's current intraday variation average was 2.51%, 2.17%, and 2.23%, respectively.
Addus HomeCare Corporation's highest amplitude of average volatility was 3.39% (day), 3.57% (last week), and 4.29% (last month), respectively.
Addus HomeCare Corporation's Stock Yearly Top and Bottom Value
Addus HomeCare Corporation's stock is valued at $77.32 at 15:22 EST, way under its 52-week high of $127.74 and above its 52-week low of $72.00.
Addus HomeCare Corporation's Moving Average
Addus HomeCare Corporation's value is under its 50-day moving average of $85.83 and way below its 200-day moving average of $88.72.4. Seacoast Banking Corporation of Florida (SBCF)
9.9% sales growth and 9.83% return on equity
Seacoast Banking Corporation of Florida operates as the bank holding company for Seacoast National Bank that provides financial services to retail and commercial customers in Florida.
Seacoast Banking Corporation of Florida's sales growth this year is anticipated to be 6.2% and 10.1% for next year.
Year-on-year quarterly revenue growth grew by 4.9%, now sitting on 343.06M for the twelve trailing months.
Volume
Today's last reported volume for Seacoast Banking Corporation of Florida is 255360 which is 15.62% below its average volume of 302654.
Seacoast Banking Corporation of Florida's sales growth for the next quarter is 9.9%. The company's growth estimates for the current quarter and the next is a negative 1.9% and negative -23.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.83%.
Volatility
Seacoast Banking Corporation of Florida's last day, last week, and last month's current intraday variation average was 2.32%, 0.92%, and 1.37%, respectively.
Seacoast Banking Corporation of Florida's highest amplitude of average volatility was 5.52% (day), 4.20% (last week), and 3.44% (last month), respectively.
Seacoast Banking Corporation of Florida's Stock Yearly Top and Bottom Value
Seacoast Banking Corporation of Florida's stock is valued at $36.31 at 15:22 EST, way under its 52-week high of $40.93 and way higher than its 52-week low of $29.28.
Seacoast Banking Corporation of Florida's Moving Average
Seacoast Banking Corporation of Florida's worth is above its 50-day moving average of $35.89 and above its 200-day moving average of $34.83.5. Canadian Pacific Railway (CP)
9.8% sales growth and 39.54% return on equity
Canadian Pacific Railway Limited, together with its subsidiaries, owns and operates a transcontinental freight railway in Canada and the United States.
Canadian Pacific Railway's sales growth this year is expected to be 7.7% and 7.3% for next year.
Year-on-year quarterly revenue growth grew by 14.6%, now sitting on 7.89B for the twelve trailing months.
Volume
Today's last reported volume for Canadian Pacific Railway is 2077730 which is 61.23% below its average volume of 5359490.
Canadian Pacific Railway's sales growth is a negative 0% for the present quarter and 9.8% for the next. The company's growth estimates for the current quarter and the next is 27.7% and 11.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 39.54%.
Volatility
Canadian Pacific Railway's last day, last week, and last month's current intraday variation average was 1.32%, 1.33%, and 1.22%, respectively.
Canadian Pacific Railway's highest amplitude of average volatility was 2.11% (day), 2.07% (last week), and 2.29% (last month), respectively.
Canadian Pacific Railway's Stock Yearly Top and Bottom Value
Canadian Pacific Railway's stock is valued at $71.90 at 15:22 EST, way below its 52-week high of $83.07 and way above its 52-week low of $64.19.